Join to access to all OVN content. Join for Free
The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges
MSL trends skills for MSLs digital literacy in healthcare future-proof MSL career patient-centric MSLs

The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges


Share This Article


Summary

This week’s guest is Stephanie Otis, Vice President Global Medical Excellence at Ferring Pharmaceuticals discusses future trends in the MSL field including the skills and competencies that will be essential for success.

Key Points

  • Scientific acumen, storytelling, and relationship-building remain the fundamental core competencies for successful MSLs, even as the role evolves with new technologies and business acumen.
  • MSLs must develop technical skills and digital literacy to adapt to rapidly changing healthcare landscapes, incorporating emerging technologies like AI and machine learning.
  • Future-proofing an MSL career involves maintaining learning agility and demonstrating enterprise leadership while ensuring patient-centricity in every aspect of their work.

Click for Source
MSL trends, skills for MSLs, digital literacy in healthcare, future-proof MSL career, patient-centric MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Layoff Ready... How to Plan and Prepare for Potential Career Transition
Partner Avatar MSL Talk: Tom Caravela, Chad Schroer

Layoff Ready... How to Plan and Prepare for Potential Career Transition

Podcast
How to create HIGH performing MSLs, teams and MSL leaders
Partner Avatar MSL Talk: Tom Caravela, Mike Penkethman

How to create HIGH performing MSLs, teams and MSL leaders

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN